Liposomal doxorubicin in combination with vinorelbine shows promise as a treatment for patients with pretreated advanced breast cancer

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1566, 2006-01, pp. : 18-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Liposomal doxorubicin effective for advanced breast cancer

By  

Inpharma, Vol. 1, Iss. 1460, 2004-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

The combination of cisplatin, epirubicin and vinorelbine effectively treats advanced breast cancer

By  

Inpharma, Vol. 1, Iss. 1428, 2004-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Vinorelbine + doxorubicin divided schedule beneficial in breast cancer

By  

Inpharma, Vol. 1, Iss. 1282, 2001-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Doxorubicin plus Ifosfamide as Salvage Treatment for Patients with Advanced Breast Cancer Refractory to Epirubicin plus Cyclophosphamide

By Polyzos A.  

Clinical Drug Investigation, Vol. 19, Iss. 5, 2000-05 ,pp. : 349-355

Adis International

Access to resources Recommend Favorite

Phase I dose escalation study of pegylated liposomal doxorubicin (Caelyx®) in combination with topotecan in patients with advanced malignancies

By Ghesquières Hervé   Faivre Sandrine   Djafari Latifa   Pautier Patricia   Lhommé Catherine   Lozahic Stéphanie   Djazouli Kamel   Armand Jean-Pierre   Raymond Eric  

Investigational New Drugs, Vol. 24, Iss. 5, 2006-09 ,pp. : 413-421

Springer Publishing Company

Access to resources Recommend Favorite